OpSens Investor Presentation 2021

OpSens is a cardiovascular medical device company leveraging proprietary optical technology for diagnostic and treatment applications. The company's core business targets coronary artery disease ($1B market) with its OptoWire flagship product, while expanding into aortic valve stenosis ($4B market) through TAVR applications expected in 2022. Strategic partnerships with Abiomed and Monteris extend technology use into ventricular assist devices and neurology laser ablation.